✦ LIBER ✦

Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG

✍ Scribed by Fiegl, M; Unterhalt, M; Kern, W; Braess, J; Spiekermann, K; Staib, P; Grüneisen, A; Wörmann, B; Schöndube, D; Serve, H; Reichle, A; Hentrich, M; Schiel, X; Sauerland, C; Heinecke, A; Rieger, C; Beelen, D; Berdel, W E; Büchner, T; Hiddemann, W

Book ID: 121379392
Publisher: Nature Publishing Group
Year: 2013
Tongue: English
Weight: 665 KB
Volume: 28
Category: Article
ISSN: 0887-6924
DOI: 10.1038/leu.2013.297

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase I Study of Fludarabine, Cytarabi

A Phase I Study of Fludarabine, Cytarabine, and Oxaliplatin Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia

✍ Tsimberidou, Apostolia Maria; Keating, Michael J.; Jabbour, Elias J.; Ravandi-Ka 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 208 KB

Sequential continuous infusion of fludar

Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome®) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients

✍ Andrea Camera; Ciro R. Rinaldi; Salvatore Palmieri; Nicola Cantore; Giuseppina M 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 159 KB

Sequential administration of irinotecan

Sequential administration of irinotecan and cytarabine in the treatment of relapsed and refractory acute myeloid leukemia

✍ Hans Minderman; Kieran L. O’Loughlin; Patrick F. Smith; Lakshmi Pendyala; Willia 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 430 KB

A Phase I Trial of Lenalidomide in Combi

A Phase I Trial of Lenalidomide in Combination with Intermediate Dose Cytarabine (IDC) in Relapsed or Refractory Acute Myeloid Leukemia (AML) Patients

✍ Vigil, Carlos E.; Griffiths, Elizabeth A.; Thompson, James E.; Brady, William E. 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 64 KB

Etoposide in combination with low-dose C

Etoposide in combination with low-dose CAG (cytarabine, aclarubicin, G-CSF) for the treatment of relapsed or refractory acute myeloid leukemia: A multicenter, randomized control trial in southwest China

✍ Zhang, Xi; Li, Yunlong; Zhang, Yanqi; Chen, Xinghua; Zhang, Cheng; Gao, Li; Kong 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 962 KB

A randomized trial of high- vs standard-

A randomized trial of high- vs standard-dose mitoxantrone with cytarabine in elderly patients with acute myeloid leukemia

✍ Feldman, E J; Seiter, K; Damon, L; Linker, C; Rugo, H; Ries, C; Jr, DC Case; Bee 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 72 KB